Monday, October 5, 2026
ExploreSearch
Via News
Enterprise AI

ERROR: Cannot generate article without source documents

The article generation system requires actual source documents from the raw_documents database to ensure factual accuracy and proper citations. The SOURCE DOCUMENTS FOR CITATION section provided is empty.

LM Salvado

April 17, 2026

ERROR: Cannot generate article without source documents
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

GENERATION ERROR:

According to the anti-hallucination rules specified in the prompt:

  1. ONLY use facts, figures, statistics from SOURCE DATA or CONTEXT
  2. NEVER invent quotes, analyst names, or research firm names
  3. Inline citations are REQUIRED with actual source documents

The provided SOURCE DOCUMENTS FOR CITATION section is empty. To generate this article properly, the system needs to:

  1. Query the Substrate database for source documents related to signal ID: ba09cd41-0613-4655-aaef-cfe49d1d36bc
  2. Extract entity names from the hypothesis (OpenAI, The Trade Desk, Criteo, Novo Nordisk, Microsoft, Alphabet, Meta)
  3. Search raw_documents table for articles mentioning these entities
  4. Provide those documents in the SOURCE DOCUMENTS FOR CITATION section

Required Fix: Run the source document retrieval function from src/article_generator.py (lines 376-508) before calling the article generation prompt.

In this story

Alphabet Inc. →Microsoft Corporation →OpenAI →Novo Nordisk →

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

Categories

Enterprise AI

Tags

errorsystem
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com